Pramipexole in treatment-resistant depression: a 16-week naturalistic study - Wikidata - awgldk - TriplyDB

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

http://www.wikidata.org/entity/Q28217267

about

sameAs

Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics Emerging targets for antidepressant therapies Novel targets for antidepressant therapies Why do some promising brain-stimulation devices fail the next steps of clinical development?The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457.Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.Striatal dopamine D2/3 receptor availability in treatment resistant depression Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression.Dopamine agonists in Parkinson's disease.Advances in the Management of Treatment-Resistant Depression Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.Adjunctive strategies in the treatment of refractory bipolar depression: clinician options in the absence of a systematic database.Potentiation strategies for treatment-resistant depression.Pramipexole in the Treatment of Refractory Depression in a Patient with Rapid Cycling Bipolar Disorder Emerging treatments for major depression.Update on the use of pramipexole in the treatment of Parkinson's disease.Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.Current status of symptomatic medical therapy in Parkinson's disease The chronic mild stress (CMS) model of depression: History, evaluation and usage Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.Therapeutic options in treatment-resistant depression.Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review.Dopamine agonist-responsive depression.Treating bipolar depression - antidepressants and alternatives: a critical review of the literature.Pramipexole augmentation in treatment-resistant major depressive disorder.Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain.Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects.Ropinirole in treatment-resistant depression: a 16-week pilot study.Compulsive eating and weight gain related to dopamine agonist use.Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain.Risk neurogenes for long-term spaceflight: dopamine and serotonin brain system.The efficacy of pramipexole, a dopamine receptor agonist, as an adjunctive treatment in treatment-resistant depression: an open-label trial.Palmitoylation as a Functional Regulator of Neurotransmitter Receptors.Efficacy of Low-dose Pramipexole Augmentation in the Treatment of Refractory Psychotic Depression Complicated with Tardive Dyskinesia: A Case Report

P2860

Q26782997-C6FF9AE7-E560-47EE-ACC7-BCAFB41B05F0 Q28247614-668EAD59-2411-4179-9804-4C5E4EC6F9CF Q28648254-A76EBE7D-CC70-4FFB-B4CB-22A18BEAD026 Q33519672-3551250E-CE86-4911-84D2-6336CF546E65 Q33593061-AC032DB1-C4CE-4DDD-B1C3-1FF6B8BCC935 Q33847160-F72BAD5E-C337-4CF5-881D-7D659F0800F1 Q34349641-34106062-ED04-4116-AB6C-BF11E6A1334B Q34550088-77887D71-2A55-4D11-A450-B4349782A28B Q34654574-DE73F96C-8537-4576-AFA3-F058DE78A0D7 Q35570952-7A7E374E-2AE9-46E4-B8C3-4D6948DDB1E7 Q35580600-D77F0C65-6D9B-4DE8-8509-D6B44AA51B1F Q36091234-F2565BFE-6F12-48D1-B6A2-52D5345D0D6C Q36150672-70B0C741-1B3B-4FED-8241-F40C1C4C4F46 Q36322234-AC370DED-85E6-4B5C-93A0-CAF20CC33135 Q36364484-F705F2E9-6BDF-4DCB-9ADF-104E66B6E7EE Q36730674-A205BBBB-4CD5-49BA-99E1-6C5788ED84EE Q36842189-C86C7B9C-2973-49A2-9FDD-35C25C8CECF2 Q36902050-D42D98FB-9C62-47C7-BE22-6EC29B02D906 Q37131229-394C0EA1-3AC7-40C2-B9F4-B3F107C1A74B Q37648894-085C675F-F755-4DEB-8AA2-06ADE7AAC888 Q37734565-26A95A58-B73E-4065-AB22-6DE0D8FCE803 Q37881968-A70BFB32-8187-49E8-B809-8E43203A376A Q38063345-2F74C715-5852-4AB8-BF18-CB9DB28B79F8 Q38443130-C35747F6-67BE-4D35-9CAD-1E996E5CC2CF Q38764892-C3B02EDE-ECCB-4184-8301-AB19B78C92D4 Q39301010-443F2C9F-5D27-42BA-A12F-18313E036493 Q42592621-86653551-2987-4097-890D-146057970F80 Q45161642-8F27035F-D25C-476A-BBF2-E515ADAEE14A Q46586074-114B0D60-CE0D-459B-8E88-089A1B7F4A7B Q46784714-BF081128-3DC4-4797-BC0D-9139776B0570 Q48250330-A56830D6-EDF2-4396-9E4B-6D283FD40223 Q48624653-3277CBA8-F211-4300-AE44-7FC7D9E63227 Q51734137-21CBD383-46DC-49F2-8F0B-0973A8AA00B1 Q55256658-EF5E2B55-864D-494F-A099-9768B245FEEC Q55969862-79D2634D-F094-4CDA-BCF4-BA3B132F37F3

P2860

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

http://www.wikidata.org/entity/Q28217267

description

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2002

@ast

scientific article (publication date: October 2002)

@en

vedecký článok (publikovaný 2002-10)

@sk

vědecký článek publikovaný v roce 2002

@cs

wetenschappelijk artikel (gepubliceerd in 2002-10)

@nl

наукова стаття, опублікована в жовтні 2002

@uk

مقالة علمية (نشرت في أكتوبر 2002)

@ar

name

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@ast

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@en

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@nl

type

label

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@ast

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@en

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@nl

prefLabel

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@ast

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@en

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@nl

P1433

Q28217267-5D67FB0C-FDB0-43FC-A263-31F1A6D2AE8C

P1476

Q28217267-C5E4E5E3-2F92-413A-8464-30A841558A35

P2093

Q28217267-0D4B9CEC-3D7C-4397-A8B3-59C8A8CE4164

Q28217267-19204241-D120-456E-B26B-3D03882A94A9

Q28217267-2BF94851-4B17-4673-82AF-5B260D671099

Q28217267-521734CD-445B-4B1E-BD0A-1EC00D90CD18

Q28217267-62B734D8-67BA-409F-976D-A483086DEF9F

Q28217267-6B715A3F-DA45-4144-BE87-D6C9B0E5A605

Q28217267-CC87852F-A087-4FA1-817D-2DFC75645919

Q28217267-DB822365-71BE-494B-87A9-FC5B6F7476A3

P2860

Q28217267-1884B16C-6D93-4DBD-800A-8656389556B7

Q28217267-209CF296-EE05-4032-8FDC-CC744A0592F1

Q28217267-287CBFAD-6B6E-43AB-BF4A-A1D9A77F6EC5

Q28217267-3127CD45-E149-4864-A072-8B24A63F8DDC

Q28217267-3427F5F2-7549-4EF3-9EE1-B09131C116BF

Q28217267-5B9D64B6-589B-4378-9748-1ABED68BB578

Q28217267-6BB68C7E-7A16-4C30-8C76-41661E85FC74

Q28217267-88AE42D8-76D2-4F29-B4E0-D702A2766744

Q28217267-AEB2294F-A422-430B-92C9-31C394DB12C2

Q28217267-B323F7D3-A6DC-45BB-80CE-1ABD6F3D3308

P304

Q28217267-24C9205D-4AF3-4E42-AA25-925FDE289FF5

P31

Q28217267-6A46F076-400D-484D-9306-A03FFD89DBC9

P356

Q28217267-1BF99C79-D12F-4BCC-8490-9FFCC16E07EA

P407

Q28217267-A37E4CAF-3897-4474-87A6-47900EF29A02

P433

Q28217267-34E09173-B52D-4480-887B-F3031E8E0AA0

P478

Q28217267-6A0B1A34-EC4E-417F-885A-BEC068AC7BC5

P50

Q28217267-5B64A204-B2EB-4330-BA4E-872F2DFD6C3F

Q28217267-672E8AF2-6C3B-4081-8213-9407706F8124

Q28217267-B91EE876-116A-479A-B893-F38D9F019A6B

P577

Q28217267-FE12B800-0C53-41C2-B9E0-BF9CABB33520

P5875

Q28217267-5F1116F5-5BFD-4C1E-AB2E-E60696797118

P698

Q28217267-678CE054-802C-456E-870A-A55A77BAAF64

P356

J.1399-5618.2002.01171.X

P1433

Bipolar Disorders

P1476

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

@en

P2093

Alfredo Gemignani

http://www.w3.org/2001/XMLSchema#string

Annalisa Bassi

http://www.w3.org/2001/XMLSchema#string

Giovanni B Cassano

http://www.w3.org/2001/XMLSchema#string

Giulia Battistini

http://www.w3.org/2001/XMLSchema#string

Lorenzo Lattanzi

http://www.w3.org/2001/XMLSchema#string

Paola Rucci

http://www.w3.org/2001/XMLSchema#string

Paolo Cassano

http://www.w3.org/2001/XMLSchema#string

Patricia R Houck

http://www.w3.org/2001/XMLSchema#string

P2860

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.

Possible use of amantadine in depression.

Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.

Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice.

Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression.

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.

Definition and epidemiology of treatment-resistant depression.

Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

Pramipexole as adjunct to haloperidol in schizophrenia

P304

307-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1399-5618.2002.01171.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Marianna Abelli

Liliana Dell'Osso

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10992492

http://www.w3.org/2001/XMLSchema#string

P698

12479663

http://www.w3.org/2001/XMLSchema#string